Deborah J Allen

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Abbott Biotechnology Ltd., Basf Aktiengesellschaft, Abbvie Biotechnology Ltd. Active years: 1999-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah J Allen. Retrieved from https://idiyas.com/inventor/deborah-j-allen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 30.8

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 10.4

ph-index = 13

Forward Citations = 1,894(Granted Patents)

Location History:

Cambridge, GB (2001 - 2007)
London, GB (1999 - 2014)

Company Filing History:

8 out of 17

Abbott Biotechnology Ltd.

patents

3 out of 10,816

Basf Aktiengesellschaft

patents

1 out of 93

Abbvie Biotechnology Ltd

patents

4. 1 out of 28

Cambridge Antibody Technology Limited

patents

5. 1 out of 259

Medical Research Council

patents

where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8753633 - Human antibodies that bind human TNFα (2014-06-17),

2. 8414894 - Human antibodies that bind human TNFα and methods of using same (2013-04-09),

3. 8372401 - Human antibodies that bind human TNFα (2013-02-12),

4. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα (2013-02-12),

5. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa (2012-06-26),

6. 8197813 - Human antibodies that bind human TNFα (2012-06-12),

7. 7588761 - Human antibodies that bind human TNFα (2009-09-15),

8. 7541031 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα (2009-06-02),

9. 7223394 - Human antibodies that bind human TNFα (2007-05-29),

10. 6509015 - Human antibodies that bind human TNFa (2003-01-21),

11. 6258562 - Human antibodies that bind human TNF&agr; (2001-07-10),

12. 6090382 - Human antibodies that bind human TNF.alpha. (2000-07-18),

13. 5872215 - Specific binding members, materials and methods (1999-02-16),

Title: The Innovative Work of Inventor Deborah J Allen in London

Introduction:

Deborah J Allen, a brilliant inventor based in London, GB, has made significant contributions to the field of biotechnology with her groundbreaking patents and inventions.

Latest Patents:

Deborah J Allen's latest patents focus on human antibodies that bind to human tumor necrosis factor α (hTNFα), demonstrating high affinity, slow dissociation rates, and the ability to neutralize hTNFα activity both in vitro and in vivo. These innovative antibodies have paved the way for novel therapeutic interventions for disorders where hTNFα activity is detrimental.

Career Highlights:

With an impressive portfolio of 13 patents, Deborah J Allen has established herself as a leading figure in the biotechnology industry. She has honed her expertise through her work at esteemed companies such as Abbott Biotechnology Ltd. and BASF Aktiengesellschaft, where she has spearheaded cutting-edge research and development initiatives.

Collaborations:

Throughout her career, Deborah J Allen has collaborated with esteemed colleagues such as Jochen G Salfeld and Zehra Kaymakcalan. Together, they have synergized their talents and expertise to bring innovative solutions to the forefront of biotechnological advancements.

Conclusion:

In conclusion, Deborah J Allen's relentless pursuit of innovation and her unwavering dedication to advancing biotechnology have solidified her position as a trailblazer in the field. Her pioneering work continues to inspire and transform the landscape of biotechnological research, offering hope for individuals suffering from disorders impacted by hTNFα activity.

Profile summary based on public USPTO records.